BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
NC Global Advantage Forum
Event | 11. 10. 2022
Karent LeVert will be speaking at the NC Global Advantage Forum on the impact of climate change on agriculture and how North Carolina's growing AgTech prowess can make a global impact.
